| Name | Title | Contact Details |
|---|---|---|
Marina Harris |
Chief People Officer | Profile |
WeConvene is the cloud-based event-management platform that helps the capital markets community book better® by making the creation, distribution, marketing and execution of professional meetings, including virtual ones, fast and easy.
RethinkFirst aims to provide enterprises, families, educators, payors, and behavioral healthcare providers affordable, best practice treatment solutions for children with special needs. Rethink is unique in our foot-print offering clinical support, best-practice tools, and research-based content via technology to all market segments, reaching more children with special needs than any other solution. Our platforms support curriculum planning, professional development, parent training, and tracking of progress. Through video and online tools, we bring to life best practice teaching, treatment, and intervention strategies that help educators, parents, and clinicians personalize instruction for every child. Rethink`s award-winning solutions are currently being used by employers, the US Department of Defense, Managed Care, Medicaid, federal, state and social service agencies, public school districts, and families nation- and worldwide.
Rental Software Solutions from InTempo. Discover the best software for independent equipment, tool, party, event and specialty rental businesses.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
ReadyTalk is one of the leading providers in Software & Internet. It is based in Denver, CO. To find more information about ReadyTalk, please visit www.readytalk.com.